Mirae Asset Global Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68.2K | Buy |
2,163
+295
| +16% | +$9.3K | ﹤0.01% | 1209 |
|
|
2025
Q1 | $60.3K | Buy |
1,868
+28
| +2% | +$904 | ﹤0.01% | 1208 |
|
|
2024
Q4 | $68.4K | Sell |
1,840
-153
| -8% | -$5.69K | ﹤0.01% | 1212 |
|
|
2024
Q3 | $61.3K | Buy |
1,993
+352
| +21% | +$10.8K | ﹤0.01% | 1266 |
|
|
2024
Q2 | $44.1K | Sell |
1,641
-21,638
| -93% | -$581K | ﹤0.01% | 1274 |
|
|
2024
Q1 | $843K | Sell |
23,279
-530
| -2% | -$19.2K | ﹤0.01% | 1631 |
|
|
2023
Q4 | $689K | Buy |
23,809
+872
| +4% | +$25.2K | ﹤0.01% | 1811 |
|
|
2023
Q3 | $632K | Buy |
22,937
+51
| +0.2% | +$1.41K | ﹤0.01% | 1767 |
|
|
2023
Q2 | $688K | Sell |
22,886
-101
| -0.4% | -$3.04K | ﹤0.01% | 1793 |
|
|
2023
Q1 | $833K | Buy |
22,987
+652
| +3% | +$23.6K | ﹤0.01% | 1636 |
|
|
2022
Q4 | $797K | Buy |
22,335
+33
| +0.1% | +$1.18K | ﹤0.01% | 1626 |
|
|
2022
Q3 | $755K | Buy |
22,302
+6,263
| +39% | +$212K | ﹤0.01% | 1641 |
|
|
2022
Q2 | $463K | Buy |
+16,039
| New | +$463K | ﹤0.01% | 1787 |
|